Gastric Ulcer (DBCOND0031714)

Identifiers

Synonyms
Ulcers, Gastric / Ulcer, Gastric / Gastric ulceration / Gastric Ulcers / Gastric Ulcer (GU) / Stomach Ulcer / Gastric ulcer / Acute gastric mucosal erosion (disorder) / Acute gastric erosions / Acute erosive gastritis (disorder) / Gastric ulcer (disorder) / Ulcer gastric / Ulcus ventriculi / Ulcer stomach

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Aluminium glycinate
A medication indicated to treat heartburn, indigestion, acid reflux, ulcers, and gas.
No drug targets
Aluminum hydroxide
An antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach.
No drug targets
Butropium
A medication indicated to treat pain caused by gastrointestinal inflammation and ulcers, or diseases of the gallbladder.
No drug targets
Calcium carbonate
An ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach.
No drug targets
Dimethicone
An ingredient used to treat dry and irritated eyes.
No drug targets
Ibuprofen
An NSAID and non-selective COX inhibitor used to treat mild-moderate pain, fever, and inflammation.
Kaolin
A natural ingredient used for the short-term symptomatic treatment of various conditions including diarrhea, skin dryness, and minor skin bleeding.
No drug targets
Magnesium hydroxide
An inorganic compound used as a laxative and antacid.
No drug targets
Magnesium trisilicate
An antacid used for the symptomatic treatment of peptic ulcers.
No drug targets
Misoprostol
A prostaglandin E1 analogue used to reduce the risk of NSAID-induced gastric ulcers and to terminate pregnancies.
Nizatidine
An H2 receptor antagonist used to treat GERD and a variety of ulcers.
Omeprazole
A proton pump inhibitor used to treat GERD associated conditions such as heartburn and gastric acid hypersecretion, and to promote healing of tissue damage and ulcers caused by gastric acid and H. pylori infection.
Pantoprazole
A proton pump inhibitor used to treat erosive esophagitis, gastric acid hypersecretion, and to promote healing of tissue damage caused by gastric acid.
Pirenzepine
An antimuscarinic agent used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
Proglumide
Not Annotated
Rabeprazole
A proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.
Ranitidine
A histamine H2 antagonist used to treat duodenal ulcers, Zollinger-Ellison syndrome, gastric ulcers, GERD, and erosive esophagitis.
Rebamipide
A gastroprotective agent used in combination with other similar therapies (e.g. proton pump inhibitors) to treat gastritis and protect the gastric mucosa.
Simethicone
An anti-flatulence agent used to relieve pressure, bloating, and symptoms referred to as gas.
No drug targets
Sucralfate
A gastro-duodenal protective agent used in the treatment of gastric and duodenal ulcers and to prevent duodenal ulcer recurrence.
Vonoprazan
A potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06526455
Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissectiontreatment4not_yet_recruiting
NCT04422405
Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGBNo drug interventionstreatmentNot Availablerecruiting
NCT06543316
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic TreatmentNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05725967
Endoscopic Metabolic and Bariatric TherapiesNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06002906
The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.prevention4recruiting
NCT05320796
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric BypassNo drug interventionsprevention4recruiting
NCT04845438
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux IndexNo drug interventionsdiagnosticNot Availableunknown_status
NCT01452763
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirinprevention3completed
NCT01456247
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirinprevention3completed
NCT01456260
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)prevention3completed
NCT01452750
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)prevention3completed
NCT02153398
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesNo drug interventionstreatment3completed
NCT02423187
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose AspirinNo drug interventionsNot AvailableNot Availablecompleted
NCT00527787
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxentreatment3completed
NCT03060733
Helicobacter Pylori Sample Collection Protocol Post Therapy SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT01946633
Remote-controlled Capsule Endoscopy: a Feasibility StudyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00594854
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotectreatment3terminated
NCT02689583
A Multi-center Study for Individual Treatment of Helicobacter Pylori InfectionNo drug interventionstreatmentNot Availableunknown_status
NCT03050307
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infectiontreatment3completed
NCT03972956
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00401752
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcertreatment3completed
NCT01562600
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience InvestigationNo drug interventionsNot AvailableNot Availablecompleted
NCT00197470
Cytokine Gene Polymorphisms in Gastric DiseasesNo drug interventionsdiagnosticNot Availableunknown_status
NCT03291418
To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjectsprevention1 / 2completed
NCT03553563
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcerprevention3completed
NCT05526339
HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese PatientsNo drug interventionspreventionNot Availableunknown_status
NCT01435525
Nexium Capsules Helicobacter Pylori Specific Clinical Experience InvestigationNo drug interventionsNot AvailableNot Availablecompleted
NCT00197457
Pepsinogens as the Early Marker of H. Pylori EradicationNo drug interventionsdiagnostic2completed
NCT06167226
Understanding Ayurveda Disease Conditions and Treatment ResponsesNo drug interventionsNot AvailableNot Availablecompleted
NCT01964131
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsNo drug interventionsbasic_science1completed
NCT00153673
Effect of Selective COX-2 Inhibition on Ulcer Healingtreatment3completed
NCT01150162
Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluationtreatment3completed
NCT05656092
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric UlcerNo drug interventionstreatment3not_yet_recruiting
NCT05448001
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcertreatment3completed
NCT00960869
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcerstreatment3completed
NCT03060746
Helicobacter Pylori Sample Collection Protocol Pre Therapy SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT05517408
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.No drug interventionstreatmentNot Availablerecruiting
NCT00149084
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pyloritreatment3unknown_status
NCT04885751
Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathyprevention4unknown_status
NCT00173953
Lymphocytic Subsets and Cytokine Production With H. Pylori InfectionNo drug interventionsdiagnosticNot Availablecompleted
NCT00511745
Safety of Rabeprazole in Patients Under Multiple TreatmentsNo drug interventionsNot AvailableNot Availableterminated
NCT01568398
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapytreatment3completed
NCT01762397
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male VolunteersNo drug interventionstreatment1completed
NCT01129011
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxentreatment3completed
NCT04410211
Comparison Between Two Types of Sedation for Elective Upper Endoscopy Proceduressupportive_careNot Availablecompleted
NCT01452711
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcertreatment3completed
NCT00132171
Helicobacter Pylori Eradication With a New Sequential TreatmentNo drug interventionstreatment3completed
NCT03057171
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNANo drug interventionsNot AvailableNot Availableunknown_status
NCT01568385
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapytreatment3completed
NCT00197418
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infectiontreatment2 / 3unknown_status
NCT00595517
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcerprevention3completed
NCT02759224
A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablettreatment1completed
NCT01190657
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric UlcerNo drug interventionstreatment4completed
NCT01729182
Nexium Capsules LDA Specific Clinical Experience InvestigationNo drug interventionsNot AvailableNot Availablecompleted
NCT00441727
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)prevention3completed
NCT04724291
MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)No drug interventionsdiagnosticNot Availablecompleted
NCT01037491
Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different AntiplateletstreatmentNot Availableunknown_status
NCT05518929
Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patientstreatment4completed
NCT02219529
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric DiseasesNo drug interventionsdiagnostic3completed
NCT00542789
Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDprevention3completed
NCT03609892
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapytreatment4completed
NCT05579444
Systems Biology of Gastrointestinal and Related DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT00428701
An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexiumtreatment4completed
NCT00527904
A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)treatment3completed
NCT02761512
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcertreatment3completed
NCT00961350
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcerstreatment3completed
NCT02299687
Influence of CYP2C19 Polymorphism on PK/PD of Omeprazolebasic_science1completed
NCT00239551
Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcertreatment4completed
NCT00839488
Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxisprevention4terminated
NCT00762359
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcerstreatment3terminated
NCT00125736
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodiumtreatment4completed
NCT02032030
Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes SurveysNo drug interventionsNot AvailableNot Availablecompleted
NCT00233389
Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcertreatment4completed
NCT00190255
Pharmacogenetics of Gastrointestinal BleedingNo drug interventionsNot AvailableNot Availablecompleted
NCT00787254
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugstreatment3completed
NCT02710994
Pharmacodynamics and Safety of CDFR0209treatment1completed
NCT00272467
Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapytreatment4completed
NCT01167101
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?treatmentNot Availablecompleted
NCT00543868
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)No drug interventionsprevention2completed
NCT05208268
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal UlcerNot AvailableNot Availablecompleted
NCT01376414
H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency DepartmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00284908
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy VolunteersNo drug interventionstreatment1completed